bioAffinity Technologies, Inc.

BIAF · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$1,105$2,822$11,414$1,361
Short-Term Investments$0$0$0$0
Receivables$1,139$812$10$2
Inventory$28$18$6$0
Other Curr. Assets$423$321$532$76
Total Curr. Assets$2,695$3,973$11,962$1,438
Property Plant & Equip (Net)$1,619$1,995$214$5
Goodwill$1,404$1,404$0$0
Intangibles$775$833$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$20$16$6$10
Total NC Assets$3,819$4,249$220$15
Other Assets$0$0$0$0
Total Assets$6,514$8,222$12,182$1,453
Liabilities
Payables$987$605$345$230
Short-Term Debt$694$460$252$11,204
Tax Payable$0$0$0$0
Deferred Revenue$24$33$0$0
Other Curr. Liab.$1,399$1,150$542$1,605
Total Curr. Liab.$3,105$2,248$1,139$13,040
LT Debt$807$1,118$0$160
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$4,044
Total NC Liab.$807$1,118$0$4,205
Other Liabilities$0$0$0$0
Cap. Leases$1,309$1,579$0$0
Total Liabilities$3,912$3,366$1,139$17,244
Equity
Pref Stock$0$0$0$4,044
Common Stock$107$66$59$19
Retained Earnings-$53,644-$44,604-$36,667-$28,513
AOCI$0$0$0-$4,044
Other Equity$56,140$49,394$47,652$12,704
Total Equity$2,602$4,855$11,043-$15,791
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,514$8,222$12,182$1,453
Net Debt$396-$1,243-$11,162$10,004